Neuropeptides and morphological changes in cisplatin-induced dorsal root ganglion neuronopathy

Experimental Neurology
I BarajonG Tredici

Abstract

Dorsal root ganglia (DRG) neuronopathy was induced in rats by chronic treatment (2 mg/kg twice a week for nine injections) with the antineoplastic drug cisplatin. Morphological alterations and changes in peptide [calcitonin gene-related peptide (CGRP), substance P, galanin (Gal), and somatostatin] concentration were studied in the DRG, the spinal cord, and the sciatic nerve. Peptide concentration was increased in DRG neurons, with CGRP and Gal showing the highest increase. Conversely, in the sciatic nerve there was a general decrease in peptide content. In DRG a reduction in the nuclear, cytoplasmic, and nucleolar areas of primary sensory neurons was evident and was accompanied by clear-cut aspects of nucleolar structural damage. In peripheral nerves only extensive morphometric determinations could evidence a reduction in nerve conduction velocities and impairment in pain detection and coordination. Some of the nerve fibers presented axonal and adaxonal accumulations, suggesting the presence of an axonopathy. These results confirm that DRG cells are the primary target of cisplatin-induced neurotoxicity. Milder alterations can be detected in peripheral nerves. The increase in peptide concentration in DRG is probably due to cispl...Continue Reading

Citations

Feb 8, 2008·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·P Ellen GrantDavid Borsook
Jan 26, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Roberto BianchiGuido Cavaletti
Feb 14, 2006·Seminars in Oncology·Frederick H HausheerFrank Lieberman
Jan 28, 2006·European Journal of Pharmacology·Judit SzilvássyZoltán Szilvássy
Jun 29, 2000·Neurologic Clinics·E S McDonald, A J Windebank
Apr 15, 2003·Neurologic Clinics·Hannah R Briemberg, Anthony A Amato
Oct 3, 1999·Experimental Neurology·G TrediciG Cavaletti
Apr 19, 2016·Pain Management·Duygu B BasCamilla I Svensson
Nov 16, 2014·Cancer Chemotherapy and Pharmacology·Julie L EisemanCharles C Horn
May 7, 2016·Journal of Chemical Neuroanatomy·Lila M LandowskiBruce V Taylor
Nov 20, 2016·Clinical Pharmacology and Therapeutics·R OharaH Inoue
Mar 4, 2015·Laboratory Animals·H Naji-EsfahaniM Rafieian-Kopaei
Mar 31, 2000·Journal of Neuroscience Research·M P ter LaakW H Gispen
Mar 8, 2016·Annals of Rehabilitation Medicine·Kang Young ParkWoo Jin Kim
Jun 27, 2015·Experimental Neurobiology·Sithiporn AgthongThuntawat Charoensub
May 12, 2005·Cancer Chemotherapy and Pharmacology·S M F JamiesonM J McKeage
May 25, 2006·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Jan OldenburgAlv A Dahl
Feb 24, 2001·Neuroreport·T SugimotoT Takano-Yamamoto
May 31, 2001·Journal of Neuropathology and Experimental Neurology·J M PowersH W Moser
Apr 28, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Roberto BianchiGuido Cavaletti
Aug 6, 2021·Frontiers in Pharmacology·Hichem BouchenakiClaire Demiot

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.